UnicoCell Biomed Co., Ltd.(TW:6794)
NT$64.80+0.30 (+0.47%)
TW:6794
UnicoCell Biomed Co., Ltd. financials statements
NT$64.80
At close:+0.30 (+0.47%)
UnicoCell Biomed Co., Ltd. (6794) Ratios
UnicoCell Biomed Co., Ltd. Ratios
TW:6794's free cash flow for Q4 2025 was NT$-24.86M. For the 2025 fiscal year, TW:6794's free cash flow was decreased by NT$-143.00K and operating cash flow was NT$-24.72M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 37.98 | 21.83 | 29.99 | 14.38 | 7.64 |
| Quick Ratio | 37.53 | 21.55 | 29.54 | 13.90 | 7.36 |
| Cash Ratio | 1.98 | 0.35 | 1.18 | 3.24 | 6.12 |
| Solvency Ratio | -1.17 | -0.70 | -0.65 | -0.83 | -1.73 |
| Operating Cash Flow Ratio | -4.41 | -2.27 | -3.88 | -3.85 | -2.89 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | NT$ 706.58M | NT$ 499.07M | NT$ 417.31M | NT$ 157.44M | NT$ 128.60M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.09 | 0.11 | 0.16 | 0.07 |
| Debt-to-Equity Ratio | 0.07 | 0.10 | 0.12 | 0.20 | 0.08 |
| Debt-to-Capital Ratio | 0.07 | 0.09 | 0.11 | 0.17 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.09 | 1.14 | 1.15 | 1.24 | 1.13 |
| Debt Service Coverage Ratio | -81.95 | -43.64 | -38.76 | -52.25 | -90.62 |
| Interest Coverage Ratio | -97.29 | -70.16 | -66.31 | -73.34 | -133.14 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.04 | 1.17 | 1.41 | 1.64 | 0.59 |
| Net Debt to EBITDA | -0.19 | -0.92 | -0.97 | -0.20 | 1.84 |
| Profitability Margins | |||||
| Gross Profit Margin | -0.73% | 64.52% | 72.78% | 56.93% | 71.32% |
| EBIT Margin | -432.77% | -287.33% | -336.15% | -624.43% | -1048.28% |
| EBITDA Margin | -364.51% | -200.83% | -228.87% | -455.85% | -726.98% |
| Operating Profit Margin | -432.77% | -322.82% | -391.56% | -639.78% | -1068.08% |
| Pretax Profit Margin | -381.48% | -291.94% | -342.06% | -633.15% | -1056.30% |
| Net Profit Margin | -381.48% | -291.94% | -342.06% | -633.15% | -1056.30% |
| Continuous Operations Profit Margin | -381.48% | -291.94% | -342.06% | -633.15% | -1056.30% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 88.15% | 90.43% | 87.36% | 98.96% | 98.90% |
| Return on Assets (ROA) | -12.14% | -11.96% | -12.26% | -22.00% | -29.01% |
| Return on Equity (ROE) | -13.27% | -13.59% | -14.10% | -27.30% | -32.84% |
| Return on Capital Employed (ROCE) | -14.08% | -13.71% | -14.39% | -23.16% | -31.60% |
| Return on Invested Capital (ROIC) | -13.98% | -13.60% | -14.26% | -22.82% | -30.61% |
| Return on Tangible Assets | -12.14% | -11.97% | -12.27% | -22.02% | -29.05% |
| Earnings Yield | -2.10% | -2.30% | -1.86% | -2.62% | -2.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.23 | 3.98 | 11.82 | 7.14 | 20.55 |
| Payables Turnover | 24.75 | 5.73 | 63.13 | 6.81 | 30.86 |
| Inventory Turnover | 3.27 | 1.45 | 0.89 | 0.78 | 0.38 |
| Fixed Asset Turnover | 0.22 | 0.21 | 0.14 | 0.08 | 0.06 |
| Asset Turnover | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 |
| Working Capital Turnover Ratio | 0.05 | 0.06 | 0.07 | 0.08 | 0.04 |
| Cash Conversion Cycle | 183.23 | 279.18 | 434.40 | 467.35 | 956.80 |
| Days of Sales Outstanding | 86.34 | 91.76 | 30.89 | 51.09 | 17.77 |
| Days of Inventory Outstanding | 111.63 | 251.12 | 409.29 | 469.89 | 950.87 |
| Days of Payables Outstanding | 14.74 | 63.70 | 5.78 | 53.62 | 11.83 |
| Operating Cycle | 197.97 | 342.88 | 440.18 | 520.98 | 968.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.50 | -1.04 | -1.22 | -1.54 | -1.64 |
| Free Cash Flow Per Share | -1.59 | -1.13 | -1.51 | -1.89 | -2.27 |
| Dividend Paid and CapEx Coverage Ratio | -16.61 | -10.78 | -4.10 | -4.35 | -2.57 |
| Capital Expenditure Coverage Ratio | -16.61 | -10.78 | -4.10 | -4.35 | -2.57 |
| Operating Cash Flow Coverage Ratio | -1.47 | -0.90 | -0.88 | -0.96 | -2.86 |
| Operating Cash Flow to Sales Ratio | -3.03 | -1.93 | -2.67 | -4.42 | -7.55 |
| Free Cash Flow Yield | -1.77% | -1.66% | -1.80% | -2.25% | -2.71% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -47.41 | -43.50 | -53.78 | -38.14 | -36.64 |
| Price-to-Sales (P/S) Ratio | 181.26 | 127.14 | 183.96 | 241.46 | 386.64 |
| Price-to-Book (P/B) Ratio | 6.30 | 5.92 | 7.58 | 10.41 | 12.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -56.36 | -60.30 | -55.48 | -44.45 | -36.89 |
| Price-to-Operating Cash Flow Ratio | -59.76 | -65.89 | -69.01 | -54.66 | -51.23 |
| Price-to-Earnings Growth (PEG) Ratio | -2.33 | -67.86 | 1.85 | 9.70 | 1.47 |
| Enterprise Value Multiple | -49.92 | -64.22 | -81.35 | -53.17 | -51.35 |
| Enterprise Value | 5.48B | 4.11B | 4.58B | 3.49B | 3.05B |
| EV to EBITDA | -49.92 | -64.22 | -81.35 | -53.17 | -51.35 |
| EV to Sales | 181.96 | 128.98 | 186.18 | 242.36 | 373.27 |
| EV to Free Cash Flow | -56.58 | -61.17 | -56.15 | -44.61 | -35.61 |
| EV to Operating Cash Flow | -59.99 | -66.84 | -69.84 | -54.86 | -49.46 |
| Tangible Book Value Per Share | 14.21 | 11.53 | 11.06 | 8.05 | 6.97 |
| Shareholders’ Equity Per Share | 14.21 | 11.54 | 11.06 | 8.06 | 6.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.49 | 0.54 | 0.46 | 0.35 | 0.22 |
| Net Income Per Share | -1.89 | -1.57 | -1.56 | -2.20 | -2.29 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.88 | 1.02 | 1.02 | 1.01 | 1.01 |
| Research & Development to Revenue | 3.07 | 2.78 | 3.37 | 5.20 | 8.54 |
| SG&A to Revenue | 1.25 | 1.09 | 1.28 | 1.76 | 2.85 |
| Stock-Based Compensation to Revenue | 0.17 | 0.04 | 0.07 | 0.21 | 0.28 |
| Income Quality | 0.80 | 0.66 | 0.78 | 0.70 | 0.71 |
Currency in TWD
